News Focus
News Focus
Followers 70
Posts 2498
Boards Moderated 0
Alias Born 08/11/2017

Re: ApollyonZ post# 40133

Thursday, 08/15/2019 12:36:29 PM

Thursday, August 15, 2019 12:36:29 PM

Post# of 71158
$LAHO Why Big Pharma Is Diving Into Gene Therapy

Big Pharma has been struggling for years to produce drugs that are major breakthroughs in medicine. For these companies, gene therapy may be the promised land.

Gene therapy—treatments designed to replace faulty genes with healthy ones—offers potential cures for hundreds of genetic diseases, like hemophilia and muscular dystrophy.

https://www.barrons.com/articles/why-big-pharma-is-diving-into-gene-therapy-51551493752

Welcome to the Age of One-Shot Miracle Cures That Can Cost Millions

Gene therapy appears to successfully treat once-incurable patients like “bubble boy” Omarion Jordan. But progress like this doesn’t come cheap.

https://www.bloomberg.com/news/features/2019-06-05/gene-therapy-appears-to-be-beating-once-incurable-diseases

Forget the 401(k), Stem Cell Benefits May Let You Cheat Death

As MyCrypto mulled what benefits to offer employees, the new blockchain startup asked them what they wanted.
..A stem cell storage company that promises the chance for a longer and healthier life, Forever Labs asserts that young,

..“There’s not much downside to banking your own biology.”

https://www.bloomberg.com/news/articles/2018-08-27/companies-offer-employees-hope-with-stem-cell-storage-benefits

China Is Getting Ready to Take On the World’s Biggest Drugmakers

..BeiGene is now worth about $9 billion on the Nasdaq..Chinese companies like BeiGene are hoping to grab a bigger slice of that pie from global drugmakers, who have for years dominated local sales of innovative therapies.

..Beijing’s ‘Made in China 2025’ initiative, intended to upgrade the country’s manufacturing industries, highlights plans to develop new targeted therapies, antibodies and vaccines while working toward breakthroughs in areas like stem cells.

https://www.bloomberg.com/news/features/2018-06-19/china-s-getting-ready-to-take-on-the-world-s-biggest-drugmakers

Beike is the world’s largest stem cell provider focusing on the research, development, and clinical translation of adult stem cells.

https://beikebiotech.com



GSCG established.. alliance.. HANK Bioengineering..Shenzhen, China

..Shenzhen HANK is a biotechnology company established in 2013 by Zhang, an award-winning scientist, microbiologist and virologist, to integrate research, development, production, and sales of biomedical products. Zhang worked at the U.S. Centers for Disease Control from 1991 to 1993, the U.S. National Institute of Health (NIH) from 1993 to 1994, and the U.S. Food and Drug Administration.. Scientific Achievement Award from the USFDA for outstanding achievement in natural killer (NK) cell research, and holds numerous awards for his work in the fields of HIV, HCV, West Nile virus, Japanese encephalitis virus, and quality performance.

..Dr. Zhang expanded on his work in stem cell research and development by launching HANK Bioengineering Co. Ltd. in Shenzhen, China. HANK is a 4,300 square foot (400 square meters) CFDA certified cGMP facility affiliated with HANK Bioengineering Institute’s Cell Biology and Molecular Immunology Laboratories. HANK has established close collaborations with more than five hospitals in China for clinical applications of its cell therapy products.

http://stemcellcenter.net/global-stem-cells-group-announces-alliance-with-hank-bioengineering-co-ltd-in-shenzhen-china/

Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study.

ZhangM3

..disease progression at 3 months after treatment was 18.8%, 50.0% and 31.2%, respectively. The total follow-up period was 2-12 months. The median progression-free survival from treatment was 7.5 months. This is the first study on the benefits of HANK cell immunotherapy for hepatic carcinoma These encouraging preliminary observations imply that HANK cell immunotherapy is safe, can improve the immune function of patients with liver cancer, and may even reduce the rate of tumor metastasis and recurrence...

https://www.ncbi.nlm.nih.gov/pubmed/28353401

GSCG Advisory Board Ming Zhang Jie, MD



http://www.stemcellsgroup.com/advisory-board/

$LAHO GSCG FUTURE OF MEDICINE$$$


Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today